Skip to main content

Isolated systolic hypertension in young males: a scoping review

Abstract

Isolated systolic hypertension typically occurs in young males; however, its clinical significance is unknown. Given the prevalence of the hypertension and its contribution to global morbidity and mortality, a synthesis of the most recent available evidence around isolated systolic hypertension is warranted. This review aims firstly to review the haemodynamic and physical characteristics indicative of cardiovascular risk in young males (aged 18 to 30 years) with isolated systolic hypertension, and secondly to synthesize the associated clinical management recommendations reported in the literature. Six databases were systematically searched for all relevant peer-reviewed literature examining isolated systolic hypertension in young males. Search results were screened and examined for validity, those that did not meet the inclusion criteria were removed. A total of 20 articles were appropriate for inclusion. Key factors indicative of cardiovascular risk in isolated systolic hypertension were characterized by several distinctive haemodynamic parameters and physical characteristics. After the literature was synthesized based around these key factors, two distinct cohorts (healthy and unhealthy) were highlighted. The healthy cohort of younger males with isolated systolic hypertension was associated with a decreased cardiovascular risk and therefore no medical interventions were recommended. The second (unhealthy) cohort was, however, associated with an increased cardiovascular risk and may therefore, benefit from antihypertensive therapy.

Background

Data published by the World Health Organization suggests that more people die from cardiovascular disease (CVD) than from any other single cause [1]. There is a direct risk of both stroke and ischemic heart disease due to hypertension alone [2]. Globally, CVD is estimated to affect more than 50% of those over the age of 60 [3]. Isolated systolic hypertension (ISH) is a subtype of hypertension. The International Society of Hypertension, defines ISH as having a brachial systolic blood pressure (SBP) greater than 140 mmHg and a brachial diastolic blood pressure (DBP) of less than 90 mmHg [4]. ISH is the most common form of hypertension among both the young and the elderly [5, 6].

In the elderly, ISH is thought to arise as a result of aortic stiffening, this occurs from the normal aging process, in combination with a number of modifiable risk factors (such as smoking and obesity) [5,6,7]. Increased pulse wave velocity (PWV) in the elderly is an indication of arterial stiffness, a strong determinant of CVD development [8]. Arterial stiffening, observed in the elderly, contributes to increased pulse pressure (PP) which causes further stiffening resulting in end-organ damage [3]. In the elderly, ISH has been clearly linked to increased risk of CVD, and as such, pharmaceutical interventions, such as antihypertensive therapy, offer significant benefits [3]. However, most studies have now concluded that ISH in the young (ISHY; ~ 18–30 years old) is likely the result of a different mechanism to that seen in the elderly.

Some research suggests the presence of ISHY is due to brachial blood pressure augmentation, elastic arteries, or as a result of increase PWV secondary to vascular stiffening, similar to that seen in elderly populations [3, 5]. The European Society of Hypertension published guidelines in 2016 that briefly mentioned the existence of ISHY, however, did little to explain its cause, cardiovascular (CV) risks and management strategies [9]. Diagnosing a young person and treating them for something that has no known associated deficits may have significant lifestyle and career implications [5]. On the other hand, if treatment is indicated, and may minimize long-term CV risk, it should not be withheld. An accurate understanding of the mechanism underpinning ISHY is necessary to define risks associated with it and to guide the clinical management of these young individuals [3]. Preliminary scoping of the literature exploring ISHY suggested that only a small portion was represented by females. For this reason, the principal concept explored in this review was centred around data from ISHY in males, irrespective of the study setting or cultural context.

The priority questions addressed in this review are two-fold; firstly, what is the clinical significance of ISHY in males, and secondly, what clinical recommendations exist in the literature regarding the management of ISHY. These questions informed the aims of this review, namely: (1) identify the key indicators of CV risk associated with ISH in males between 18 and 30 years of age, and (2) determine how ISH can be managed within this cohort. Given the prevalence of hypertension and its contribution to global morbidity and mortality, ISHY certainly warrants attention.

Design

This scoping review adopted the JBI evidence-implementation approach, as set out by Peters et al. [10].

Preliminary searches for CV risk factors (see Appendix for details [11,12,13,14,15]) and interventions associated with ISH identified a wide range of research designs and outcome measures, ruling out a systematic review with meta-analysis. It was also identified that most established research on ISH was conducted on the elderly. Within the younger population, only a small portion was represented by females and results were, therefore, clinically negligible. For this reason, the review focused on young males as its target population, irrespective of the cultural context or setting (acute, community) in which the data were collected. Generally, scoping reviews are indicated for identifying and analysing knowledge gaps, clarifying concepts and definitions, and mapping evidence to inform practice [16, 17]. Therefore, a scoping review was the methodology selected to afford a broader lens to explore CV risk factors associated with ISH in young males, and respective management recommendations.

Search methods

A comprehensive literature search of six databases was conducted, including Johanna Briggs, Embase, CINAHL, MEDLINE, Cochrane Library, and PubMed. All the searches were executed in March 2020, several rounds of preliminary searches were conducted as per the systematic scoping methodology to identify the best MeSH terms (descriptors or subject headings), keywords, and to test search strategies [10]. The search terms used included the following MeSH, keywords and Boolean terms: “systolic hypertension” OR “isolated systolic hypertension” AND “young”. Years of coverage were 2000 to 2020. Study participant limiters such as gender and age were applied, and the search strategy was customized to each database.

Inclusion and exclusion

Only literature that met the inclusion criteria were included in the review namely: (1) full-text articles published in the English language within the last 20 years, (2) studies conducted in the young males 19 to 24 years or 19 to 44 years depending on the database limiters, (3) studies that evaluate SBP, and (4) studies published in peer-reviewed journals. Article results that did not differentiate gender and age groups were excluded, as it was not possible to stratify relevant data. Studies assessing cohorts with pre-existing medical conditions we also excluded as ISH could not be examined independently (Fig. 1).

Fig. 1
figure1

Schematic PRISMA-type illustration of the systematic study selection process undertaken to inform this review

Data collection and analysis

A total of 452 articles were reviewed by author one and reduced to 127, after the removal of duplicates, were identified that met the initial search criteria (Fig. 1). These were independently reviewed by a second author. Consensus was achieved on all papers. Articles that were not in English, focused on a cohort with pre-existing medical conditions or were not published within the last 20 years were excluded (n = 97) (Fig. 1). The remaining 20 full-text articles were used to inform the review. A PRISMA flow diagram (Fig. 1) illustrates the scoping review process [18].

A data extraction table (Table 1) was developed to chart the results. It enabled the extraction and synthesis of the key findings from 14 articles, including: authors, year of publication, study design and population, study aims and methodology, and recommendations/results. Development of these conceptual categories was iterative and undertaken to ensure alignment with the review questions [10]. The authors independently evaluated each of the studies for several characteristics, including study design, aim, sample size, population, methodology and key findings, as per the scoping review framework [10]. Six articles (not included in the extraction table) were used to contextualize, inform and confirm the clinical recommendations and therefore, did not contribute directly to the data extracted from the studies. Evidence from the studies that met the selection criteria was tabulated and then synthesized in the results section to enable the development of an overarching picture of the clinical significance of ISHY in males, and to propose clinical recommendations in regard to the management of ISHY on the basis of synthesis of best available evidence.

Table 1 Included papers

A total of 20 full-text articles were used to inform the review. These included large, multi-ethnical prospective cohort studies, cross-sectional studies, an experimental study, an observational study, and reviews. The studies involved a total of 1,266,982 participants aged 18 to 49 years, with data collected from 1969 to 2016 (Table 1). The physical characteristics and haemodynamic parameters of these individuals were assessed to understand the potential CV risk of ISHY in males aged 18 to 30, and how ISHY can be most appropriately managed clinically. Populations studied included Vietnamese, American, Swedish, Ugandan, and European backgrounds. Participants were included from large clinical database studies such as the Hypertension and Ambulatory Recording Venetia Study (HARVEST), the Atherosclerosis Risk in Young Adults study, the ENIGMA study, National Health and Nutrition Examination Survey (NHANES), and the Healthy Life in an Urban Setting (HELIUS) study.

To develop an understanding of CV risk, most studies drew a comparison between normal blood pressure and other hypertension subtypes, including ISH, systolic-diastolic hypertension (SDH) and diastolic hypertension. Radchenko et al. [13] noted that the occurrence of hypertension subgroups increased with age, except for ISH which was the most prevalent in males aged 18 to 29 [11, 22]. In terms of management, only 32% of ISH individuals were found to receive antihypertensives in comparison to 52% of SDH individuals and were less likely to receive a diagnosis [22]. From the included studies, key data fields emerged to determine CV risk. This included haemodynamic findings (PP amplitude, PWV, augmentation index [AIx], cardiac output [CO], and central blood pressure [cBP]), modifiable and nonmodifiable risk factors (weight, height, smoker status, physical activity level); see Appendix for more details on CV risk factors.

ISHY and CV risk

Haemodynamic measurements were consistently used to determine potential CV risk associated with ISHY. Some common ISHY haemodynamic findings included a normal to low heart rate, increased CO, an increased PP amplitude as well as a decreased AIx [12, 19]. In some cases, there was no significant increase in PP amplitude. ISHY participants were also found to have an increased aortic PWV and decreased brachial PWV [21]. This is indicative of increased arterial compliance and a lack of peripheral vascular resistance (PVR) [21]. Consistent with this finding, McEniery et al. [27], found that in 17- to 27-year-old males, PVR in ISH was comparable to normotensive individuals.

Central PP and cBP appear to be a more accurate and useful indicator than brachial BP, as they provide a better indication of the BP exerted on the major organs [28]. In most cases, ISHY individuals were found to have a cBP classified as high-normal, however, in some cases, it was elevated further, and in other cases, it was found to be low [12, 19, 24, 26]. Radchenko et al. [13], noted that independent risk factors for increased cBP in ISHY, a measurement strongly associated with CV risk, included height less than 178 cm, weight greater than 91 kg and DBP more than 80 mmHg. Having two or more of these factors increased the chance of elevated cBP at least 10-fold. Sundstrom et al. [25], also noted the significance of an increased DBP; their study included a total of 1,207,141 males conscripted to the Swedish military forces. DBP less than 90 mmHg was found to be unrelated to mortality, however above 90 mmHg there was a significant increase [25]. Elevated cBP corresponded to elevated systemic vascular resistance. Saladini et al. [14], identified that ISHY with a low or normal cBP was associated with reduced CV risk. ISHY with low or normal cBP were younger, had a lower body mass index (BMI), lower total cholesterol, low triglycerides and smoked less than all other hypertensive subgroups as well as normotensive individuals.

Three studies suggested ISH is spurious, while four studies concluded that ISH presents a similar risk to that of high-normal BP and thus, conclusive findings remain to be established. Yano et al. [24] concluded ISH individuals that were young or middle-age had an increased CV risk, and estimated the risk to be similar to that of high-normal BP, but did not recommend pharmacological treatment. Eeftinck Schattenkerk et al. [19], also concluded that ISH posed a similar CV risk as having a high-normal BP and identified common features in the population tested that included; being male, taller, Dutch, younger, having a larger stroke volume (SV) and reduced AIx. Grebla et al. [11], agreed that the ISHY cohort was predominately male and younger than those of other hypertension subgroups. They additionally found that ISH individuals in the 18- to 39-year-old cohort had an increased BMI, total cholesterol, SBP, DBP, PP and were more likely to be of a lower socioeconomic status compared to the normotensive cohort. PP was also noted to be substantially higher than all other groups.

Mahmud and Feely [12], studied a group of 174 healthy medical students, 11 of which had ISH. They concluded ISHY was associated with normal cBP, tall, active, non-smoking males, which is consistent with Radchenko et al. [13], who additionally reported ISHY individuals to have a slower resting heart rate. The study suggested that the results may be due to an exaggerated first systolic peak in the brachial waveform. The increased pulse transit time seen in the ISH cohort causes a delayed return from peripheral vessels resulting in pulse wave reflections having the greatest positive impact on the peripheral arteries and the least on the central vessels [12]. McEniery et al. [27] suggested that the elevated systolic value in young males is due to decreased PVR, increased SV and aortic stiffness, in contrast with SDH, that is seen subsequent to increased PVR. This study of 1008 participants ages 17 to 27 years, concluded that ISHY is associated with increased physical activity, less smoking, increased height and weight compared to other cohorts. Palatini et al. [20], also found ISHY predominately occur in healthy, fit, young males with a low resting heart rate. The study additionally reported no increased risk of ISHY individuals developing SDH hypertension in the 6.9-year follow-up assessment. As a result, they concluded that ISHY does not imply increased CV risk [20].

Cohorts and CV risk

ISHY was associated with positive haemodynamic, modifiable and nonmodifiable factors [12, 20, 27] there are some consistent findings such as ISHY predominately occurs in males with a comparatively higher BMI [11, 14, 19]. Among the inconsistent findings, there have been two notable cohort themes drawn. The first (unhealthy cohort) is that ISHY is characterized by individuals being current smokers, of lower socioeconomic status, decreased physical activity and increased BMI [11]. The second cohort theme (healthy cohort), in complete contrast, is that ISHY is characterized by individuals being taller, more physically active, the youngest in the age bracket, lower blood cholesterol levels, are non-smokers; thus depicted as exceptionally healthy [5, 12, 20, 26]. Correspondingly, the haemodynamic findings also identified two distinct cohorts among ISHY, those with increased cBP and those with normal or low cBP. Those with elevated cBP have been linked to CV risk through physical, social and additional haemodynamic factors; those with normal or low cBP have been associated with healthy lifestyle choices, physical activity and low-risk CV haemodynamic parameters [14, 19].

Despite several studies exploring many elements of ISH in younger male populations, the clinical significance of ISH remains unclear. Some studies have concluded that it is spurious and does not require intervention, while others have concluded it is related to increased CV risk. The findings appear to be influenced by the age of participants studied and the cohort size. Cohorts that included males up to 49 years of age were more likely to identify greater CV risk associated with ISH than studies of a younger cohort. Larger cohorts were also more likely to find negative rather than positive CV association with ISH. Over the last decade, the incidence of ISH has increased [29]. This highlights the need for clear evidence around management and consistent, evidence-based, recommendations for the management of ISHY.

Trajectory and CV risk

Throughout the scoping review, the prevalence of ISH was often described as being represented by a J-curve [5, 7]. This supports the notion that the pathophysiology of ISH differs between the young and the elderly. While ISHY may develop into SDH, evidence suggests most people do not maintain ISH throughout life [5, 7]. Ultimately, individuals need to be traced to determine whether ISHY progresses into SDH and whether they are at an increased risk of specific CV events.

Haemodynamic findings and CV risk

To review the potential CV risk associated with ISHY, the haemodynamic findings were analysed and summarised in Table 1. Briefly, increased PWV and both normal and increased PP amplification, are noted in ISHY [13, 27], however, ISHY is rarely associated with an increased heart rate [5]. Increase velocity may occur secondary to increased CO which has been noted in ISHY, and increased distance which is also seen in the taller stature of ISHY individuals [12, 19, 21, 27, 30]. PP demonstrated negative CV effects in the elderly, but not in younger populations [31]. Indeed, increased PP amplitude, a common finding in ISHY, may have positive as opposed to negative CV implications, as seen in the elderly [5].

Increased CO, a feature of ISHY, has also been noted in overweight and obese individuals (a modifiable CV risk factor), regardless of their SBP [3]. SBP in these individuals does, however, correlate with increased PVR [3], unlike ISHY in healthy body weight ranges [3, 27]. This suggests that increased CO and SBP in ISHY who are overweight may have a different causative mechanism [3].

ISH in combination with increased heart rate results in increased arterial stiffness and thus an overall increase in CV risk [5], this may be due to a neurogenic abnormality involving sympathetic nervous system dysregulation [32]; referred to as a ‘hyperkinetic circulation’ [5], and associated with an elevation in norepinephrine levels [33]. It is unknown whether this hyperkinetic state precedes sustained SDH. If this adrenergic activation was responsible for ISHY it would likely result in adverse effects [5]. An increase of 10 beats/min would cause an increase in PWV of 0.17 m/sec resulting in an increase in vascular aging by 2 years at 40 years old, however, at the age of 20, this would equate to 5 years of vascular aging [5]. In most cases, ISHY individuals were found to have a heart rate similar or lower than the comparative normotensive cohorts [20].

Completeness and applicability of evidence

ISHY primarily occurs in males with an increased BMI. However, there were two groups of common findings associated with participant profiling. The first cohort (profile) was characterized by being a smoker, having a lower socioeconomic status and being less physically active. The second cohort was characterized by being taller, more physically active, the youngest in the age bracket, having a low cholesterol, being non-smokers and depicted as exceptionally healthy [12, 20]. This first, less healthy cohort, has haemodynamic findings associated with increased CV risk, such as increased cBP and increased PVR. The second healthy cohort has haemodynamic findings associated with reduced CV risk, including reduced PVR and low or normal cBP [14, 19]. Ascertaining the overall risk of ISHY becomes more difficult as these two opposing cohorts are, perhaps unknowingly, grouped and analysed together.

To obtain a complete understanding of ‘true’ ISHY, these two cohorts, of healthy and unhealthy males aged 18 to 30 years, need to be studied independently. Their haemodynamic characteristics including cBP, brachial BP, aortic PWV, brachial PWV, PP amplitude, AIx, SV, heart rate; as well as the physical characteristics and overall health of the individual must be examined. Variables including pre-existing medical conditions and familial history of CVD should be normalized to appreciate the effect of ISHY. Additionally, participants should also be followed long-term.

Management of ISHY

Analysis of the available literature supports several clinical recommendations that may assist in managing ISHY. Individuals aged 18 to 30 with suspected ISH should first have their BP taken in a seated position for consistency, ideally in a non-stressful environment, after no recent physical exertion, to avoid false positives [34]. The heart rate and BP should be assessed twice in the first visit, 10 min apart, to improve accuracy [34]. If one of these blood pressure readings is high, the individual should return one to 2 weeks later to repeat the first visit. If the SBP remains above 140 mmHg, a 24-h ambulatory BP monitor should be fitted. This is necessary to eliminate white coat hypertension (WCH). If the mean SBP during the awake hours remains high, the individual should be assessed for end-organ damage and routine pathology including cholesterol [5]. cBP, evaluated with the SphygmoCor, is a more accurate indicator of CV risk than brachial BP [19]. If pathology, cBP and heart rate are normal, antihypertensive medications are not indicated [5]. Pharmaceutical management of BP may be expensive and can induce secondary effects, and restrict engagement in some activities, which in turn, may impact the quality of life and reduce physical fitness [3]. If cBP is low or normal and heart rate is elevated, assessing for an increased sympathetic drive should be considered [5]. If pathology is abnormal, there is an indication of end-organ dysfunction, or if cBP is elevated, there is a potential that antihypertensive medications could reduce CV risk in this group. A flowchart (Fig. 2) of proposed actions has been devised to summarise the management of ISHY, based on the literature used in the review.

Fig. 2
figure2

Proposed clinical management of suspected isolated systolic hypertension (ISH) in males 18 to 30 years of age. BP, blood pressure; SBP, systolic blood pressure; DBP, diastolic blood pressure; cBP, central blood pressure

Consideration of pharmaceutical treatment

Based on this review of literature, treatment is not indicated in ISHY who are healthy and have otherwise normal haemodynamic findings. In high-risk individuals with ISH, antihypertensives may be considered. The therapeutic benefit of B-blockers is unlikely to outweigh the adverse effects in the cohort of young males [3]. McEniery et al. [3], suggested reducing CO as an option to reduce SBP and therefore the potential progression of hypertension, however, the reduced PVR observed in ISHY would challenge this recommendation. Increased CO in ISHY, of healthy body weight, has not been proven to have a negative CVD effect.

Consideration of non-pharmaceutical treatment

Healthy lifestyle choices, such as weight loss, dietary interventions (reduced sodium intake), and increased physical activity are all recommended approaches in the management of ISHY [35]. A meta-analysis by Neter et al. [36] demonstrated that a 5-kg weight loss and/or physical activity, in adults under 45 years of age, led to a 5 mmHg SBP reduction. While the Dietary Approaches to Stop Hypertension (DASH) diet resulted in a significantly lower SBP at every sodium level (high, intermediate, and low levels) and in a significantly lower DBP at the high and intermediate sodium levels [37].

Limitations

The scoping review was limited by the number of studies included, and that one author initially searched and compiled the literature. This was an unfunded study and so despite that this is clearly an international clinical issue, only research published in English was included in the review. A significant limitation in many of the reviewed studies was the use of BMI to determine the healthy weight of an individual. BMI is widely known to be a poor indicator of total body adiposity [38]. Muscular individuals may be classified as being overweight, using a BMI scale, due to their muscular weight as opposed to excess adiposity. In order to improve this in future studies, an alternative method should be used, such as the fat mass index or an assessment that incorporates height, hip and waist ratio [37]. A further limitation is that not all studies utilized a 24-h ambulatory blood pressure monitor to differentiate ISH from WCH. This is essential as a large portion of suspected ISHY is WCH. Another significant limitation of these studies was the accurate representation of the young male population; most studies incorporate participants who were middle-aged, and this misrepresents ISHY. Additionally, findings may be impacted by differential impacts of race on blood pressure, however this data is not yet available when looking solely at the young male cohort. The last significant limitation was the lack of adherence to identifying and acknowledging all individuals with pre-existing health conditions or relevant familial medical history. Consequently, the studied cohorts may not have been entirely healthy (or similar) to start with, and the CV risk of ISH could not be independently examined.

Conclusions

ISHY is associated with decreased AIx, decreased brachial PWV, increased aortic PWV, increased CO and increased or normal PP amplitude. What has been made clear through this review is that there are two distinct cohorts within the ISHY population. The first is characterized by healthy modifiable and nonmodifiable features, including haemodynamic profiling, and the second subgroup has demonstrated physical characteristics and haemodynamic profiling consistent with poor health and may be at an increased CV risk. An ISHY management plan, based on these data has been proposed and could be explicitly validated in future research.

Availability of data and materials

Published data over last 20 years.

Abbreviations

Aix:

Augmentation index

BMI:

Body mass index

BP:

Blood pressure

cBP:

Central blood pressure

CO:

Cardiac output

CV:

Cardiovascular

CVD:

Cardiovascular disease

DBP:

Diastolic blood pressure

ISH:

Isolated systolic hypertension

ISHY:

Isolated systolic hypertension in the young

PP:

Pulse pressure

PVR:

Peripheral vascular resistance

PWV:

Pulse wave velocity

SBP:

Systolic blood pressure

SDH:

Systolic-diastolic hypertension

SV:

Stroke volume

WCH:

White coat hypertension

References

  1. 1.

    World Health Organization. Cardiovascular diseases (CVDs). 2017. https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds). Accessed 17 May 2017.

    Google Scholar 

  2. 2.

    Division for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion. Facts about hypertension. 2020. https://www.cdc.gov/bloodpressure/facts.htm. Accessed 4 Apr 2020.

    Google Scholar 

  3. 3.

    McEniery CM, Franklin SS, Cockcroft JR, Wilkinson IB. Isolated systolic hypertension in young people is not spurious and should be treated: pro side of the argument. Hypertension. 2016;68:269–75.

    CAS  Article  Google Scholar 

  4. 4.

    Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75:1334–57.

    CAS  Article  Google Scholar 

  5. 5.

    Palatini P, Rosei EA, Avolio A, Bilo G, Casiglia E, Ghiadoni L, et al. Isolated systolic hypertension in the young: a position paper endorsed by the European Society of Hypertension. J Hypertens. 2018;36:1222–36.

    CAS  Article  Google Scholar 

  6. 6.

    Bavishi C, Goel S, Messerli FH. Isolated systolic hypertension: an update after SPRINT. Am J Med. 2016;129:1251–8.

    Article  Google Scholar 

  7. 7.

    Saladini F, Palatini P. Isolated systolic hypertension in young individuals: pathophysiological mechanisms, prognostic significance, and clinical implications. High Blood Press Cardiovasc Prev. 2017;24:133–9.

    Article  Google Scholar 

  8. 8.

    Supiano MA, Lovato L, Ambrosius WT, Bates J, Beddhu S, Drawz P, et al. Pulse wave velocity and central aortic pressure in systolic blood pressure intervention trial participants. PLoS One. 2018;13:e0203305.

    Article  Google Scholar 

  9. 9.

    Lurbe E, Agabiti-Rosei E, Cruickshank JK, Dominiczak A, Erdine S, Hirth A, et al. 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens. 2016;34:1887–920.

    CAS  Article  Google Scholar 

  10. 10.

    Peters MD, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. Guidance for conducting systematic scoping reviews. Int J Evid Based Healthc. 2015;13:141–6.

    Article  Google Scholar 

  11. 11.

    Grebla RC, Rodriguez CJ, Borrell LN, Pickering TG. Prevalence and determinants of isolated systolic hypertension among young adults: the 1999-2004 US National Health and Nutrition Examination Survey. J Hypertens. 2010;28:15–23.

    CAS  Article  Google Scholar 

  12. 12.

    Mahmud A, Feely J. Spurious systolic hypertension of youth: fit young men with elastic arteries. Am J Hypertens. 2003;16:229–32.

    Article  Google Scholar 

  13. 13.

    Radchenko GD, Torbas OO, Sirenko YM. Predictors of high central blood pressure in young with isolated systolic hypertension. Vasc Health Risk Manag. 2016;12:321–8.

    CAS  Article  Google Scholar 

  14. 14.

    Saladini F, Santonastaso M, Mos L, Benetti E, Zanatta N, Maraglino G, et al. Isolated systolic hypertension of young-to-middle-age individuals implies a relatively low risk of developing hypertension needing treatment when central blood pressure is low. J Hypertens. 2011;29:1311–9.

    CAS  Article  Google Scholar 

  15. 15.

    Hickson SS, Nichols WW. Yasmin, McDonnell BJ, Cockcroft JR, Wilkinson IB, et al. influence of the central-to-peripheral arterial stiffness gradient on the timing and amplitude of wave reflections. Hypertens Res. 2016;39:723–9.

    Article  Google Scholar 

  16. 16.

    Peterson J, Pearce PF, Ferguson LA, Langford CA. Understanding scoping reviews: definition, purpose, and process. J Am Assoc Nurse Pract. 2017;29:12–6.

    Article  Google Scholar 

  17. 17.

    Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19–32.

    Article  Google Scholar 

  18. 18.

    Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.

    Article  Google Scholar 

  19. 19.

    Eeftinck Schattenkerk DW, van Gorp J, Vogt L, Peters RJ, van den Born BH. Isolated systolic hypertension of the young and its association with central blood pressure in a large multi-ethnic population. The HELIUS study. Eur J Prev Cardiol. 2018;25:1351–9.

    Article  Google Scholar 

  20. 20.

    Palatini P, Saladini F, Mos L, Fania C, Mazzer A, Casiglia E. Clinical characteristics and risk of hypertension needing treatment in young patients with systolic hypertension identified with ambulatory monitoring. J Hypertens. 2018;36:1810–5.

    CAS  Article  Google Scholar 

  21. 21.

    Gaddum N, Alastruey J, Chowienczyk P, Rutten MCM, Segers P, Schaeffter T. Relative contributions from the ventricle and arterial tree to arterial pressure and its amplification: an experimental study. Am J Physiol Heart Circ Physiol. 2017;313:H558–67.

    Article  Google Scholar 

  22. 22.

    Johnson HM, Bartels CM, Thorpe CT, Schumacher JR, Pandhi N, Smith MA. Differential diagnosis and treatment rates between systolic and diastolic hypertension in young adults: a multidisciplinary observational study. J Clin Hypertens (Greenwich). 2015;17:885–94.

    Article  Google Scholar 

  23. 23.

    Musinguzi G, Van Geertruyden JP, Bastiaens H, Nuwaha F. Uncontrolled hypertension in Uganda: a comparative cross-sectional study. J Clin Hypertens (Greenwich). 2015;17(1):63–9.

    Article  Google Scholar 

  24. 24.

    Yano Y, Stamler J, Garside DB, Daviglus ML, Franklin SS, Carnethon MR, et al. Isolated systolic hypertension in young and middle-aged adults and 31-year risk for cardiovascular mortality: the Chicago heart association detection project in industry study. J Am Coll Cardiol. 2015;65:327–35.

    Article  Google Scholar 

  25. 25.

    Sundstrom J, Neovius M, Tynelius P, Rasmussen F. Association of blood pressure in late adolescence with subsequent mortality: cohort study of Swedish male conscripts. BMJ. 2011;342:d643.

    Article  Google Scholar 

  26. 26.

    Hulsen HT, Nijdam ME, Bos WJ, Uiterwaal CS, Oren A, Grobbee DE, et al. Spurious systolic hypertension in young adults; prevalence of high brachial systolic blood pressure and low central pressure and its determinants. J Hypertens. 2006;24:1027–32.

    CAS  Article  Google Scholar 

  27. 27.

    McEniery CM, Yasmin WS, Maki-Petaja K, McDonnell B, Sharman JE, et al. Increased stroke volume and aortic stiffness contribute to isolated systolic hypertension in young adults. Hypertension. 2005;46:221–6.

    CAS  Article  Google Scholar 

  28. 28.

    Lurbe E, Redon J. Isolated systolic hypertension in young people is not spurious and should be treated: con side of the argument. Hypertension. 2016;68:276–80.

    CAS  Article  Google Scholar 

  29. 29.

    Qi SF, Zhang B, Wang HJ, Yan J, Mi YJ, Liu DW, et al. Prevalence of hypertension subtypes in 2011 and the trends from 1991 to 2011 among Chinese adults. J Epidemiol Community Health. 2016;70:444–51.

    Article  Google Scholar 

  30. 30.

    Pickering TG. Isolated systolic hypertension in the young. J Clin Hypertens (Greenwich). 2004;6:47–8.

    Article  Google Scholar 

  31. 31.

    Vaccarino V, Berger AK, Abramson J, Black HR, Setaro JF, Davey JA, et al. Pulse pressure and risk of cardiovascular events in the systolic hypertension in the elderly program. Am J Cardiol. 2001;88:980–6.

    CAS  Article  Google Scholar 

  32. 32.

    Mancia G, Grassi G. The autonomic nervous system and hypertension. Circ Res. 2014;114:1804–14.

    CAS  Article  Google Scholar 

  33. 33.

    Grassi G, Mark A, Esler M. The sympathetic nervous system alterations in human hypertension. Circ Res. 2015;116:976–90.

    CAS  Article  Google Scholar 

  34. 34.

    Hwang KO, Aigbe A, Ju HH, Jackson VC, Sedlock EW. Barriers to accurate blood pressure measurement in the medical office. J Prim Care Community Health. 2018;9:2150132718816929.

    Article  Google Scholar 

  35. 35.

    Yano Y, Lloyd-Jones DM. Isolated systolic hypertension in young and middle-aged adults. Curr Hypertens Rep. 2016;18:78.

    Article  Google Scholar 

  36. 36.

    Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2003;42:878–84.

    CAS  Article  Google Scholar 

  37. 37.

    Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. N Engl J Med. 2001;344:3–10.

    CAS  Article  Google Scholar 

  38. 38.

    Nuttall FQ. Body mass index: obesity, BMI, and health: a critical review. Nutr Today. 2015;50:117–28.

    Article  Google Scholar 

Download references

Acknowledgments

Ms. Bonnie Dixon, health librarian who assisted in constructing the search strategy.

Implications for practice

Healthy young males with ISH, determined by a 24-h ambulatory blood pressure monitor, who have normal central blood pressure (cBP), normal heart rate, and no indication of organ damage should be encouraged to maintain a healthy lifestyle, a healthy level of exercise and future routine health check-ups. Young males with isolated systolic hypertension who have a high cBP or a continuously high heart rate or indication of organ damage should have further investigations as they are likely to be at an increased CV risk. This cohort is likely to benefit from antihypertensive therapy.

Implications for research

To establish a complete understanding of the clinical risks in isolated systolic hypertension in the young (ISHY) a longitudinal study should be conducted. The baseline cohort should include young males aged 18 to 25 who are otherwise healthy with no significant familial history. The cohort should be separated into those with high central blood pressure (cBP) and those with low or normal cBP to assess the development of hypertension and cardiovascular events. The outcome of this research will more accurately guide the clinical management of ISHY.

Funding

None.

Author information

Affiliations

Authors

Contributions

HS and MB conceptualized review, and drafted the methodology. All authors aided in drafting and revised the manuscript, while HS performed data analysis and its interpretation. All authors approved the final manuscript.

Corresponding author

Correspondence to Matthew J. Barton.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Scott, H., Barton, M.J. & Johnston, A.N.B. Isolated systolic hypertension in young males: a scoping review. Clin Hypertens 27, 12 (2021). https://doi.org/10.1186/s40885-021-00169-z

Download citation

Keywords

  • Blood pressure
  • Male
  • Cardiovascular diseases
  • Hypertension